Pharmaceuticals & Biopharmaceuticals
Featured Topics in Industries: Paper & Pulp & Wood | Plastics & Rubber | Electrical Equipment | Telecommunications | University | all topics
Filter by: News | Articles | New to Market | Tools & Technology | Videos | Podcasts | Journal Articles | White Papers
Mar 18 | News
A team of McGill Chemistry Department researchers led by Dr. Hanadi Sleiman has achieved a breakthrough in the development of nanotubes—tiny "magic bullets" that could one day deliver drugs to specific diseased cells.
Mar 18 | News
Duke Univ. researchers have devised a method to dry and preserve proteins in a glassified form that seems to retain the molecules' properties as workhorses of biology.
Mar 16 | News
Magic bullets, also called silver bullets, because of the folkloric belief that only silver bullets can kill supernatural creatures, remain the goal of drug development efforts today. A team of scientists at Washington Univ. in St. Louis is currently working on a magic bullet for cancer. But their bullets are gold rather than silver.
Mar 16 | News
The film "Avatar" isn't the only 3-D blockbuster making a splash this winter. A team of scientists from Houston's Texas Medical Center this week unveiled a new technique for growing 3-D cell cultures, a technological leap from the flat petri dish that could save millions of dollars in drug-testing costs.
Mar 10 | News
For decades, the traditional practice in animal testing has been standardization, but a study involving Purdue Univ. has shown that adding as few as two controlled environmental variables to preclinical mice tests can greatly reduce costly false positives, the number of animals needed for testing and the cost of pharmaceutical trials.
Mar 1 | News
Researchers have been able to see how heart failure affects the surface of an individual heart muscle cell in minute detail, using a new nanoscale scanning technique developed at Imperial College London. The findings may lead to better design of beta-blockers.
Mar 1 | News
Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 billion (US$ 7.2 billion).
Feb 9 | News
People with cystic fibrosis frequently have lung infections that defy treatment. These chronic infections are often caused by common, environmental microbes that mutate in ways that let them live and thrive in viscous lung secretions. The same adaptations also make the pathogens less likely to be killed off by powerful antibiotics.
Feb 8 | News
Northwestern Univ. researchers are the first to design a bioactive nanomaterial that promotes the growth of new cartilage in vivo and without the use of expensive growth factors. Minimally invasive, the therapy activates the bone marrow stem cells and produces natural cartilage. No conventional therapy can do this.
Feb 5 | News
Using lasers and nanoparticles, scientists at Rice Univ. have discovered a new technique for singling out individual diseased cells and destroying them with tiny explosions. The scientists used lasers to make "nanobubbles" by zapping gold nanoparticles inside cells.